Joseph Saddik | Pharmacology, Toxicology and Pharmaceutical Science | Best Innovation Award

Published on by Academic Excellence

Best Innovation Award

Joseph Saddik
Pfizer,United States

Joseph Saddik
Affiliation Pfizer
Country United States
Scopus ID 57223125865
Documents 2
Citations 25
h-index 2
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Excellence Awards
ORCID 0000-0003-1490-9517

Joseph Saddik is identified with research in pharmaceutical science, particularly powder rheology, tablet compaction, compactability, and manufacturing-related performance of acetaminophen tablets. His listed publications address formulation and processing variables associated with tablet manufacture and the prediction or mitigation of sticking during compression. [1][2]

Abstract

The research record associated with Joseph Saddik centers on pharmaceutical powder processing and tablet manufacturing. The documented work examines powder rheology, tablet compactability, and sticking behavior, with particular attention to formulation factors, glidant selection, punch-metal effects, and multivariate analytical approaches. These topics are relevant to pharmaceutical manufacturing because powder flow and compaction characteristics can influence tablet quality and process performance. [2][3]

Keywords

Pharmaceutical science; powder rheology; tablet compression; acetaminophen; compactability; sticking; glidants; punch metals; multivariate analysis.

Introduction

Tablet manufacture involves interconnected material and process variables. Acetaminophen is frequently used as a model active pharmaceutical ingredient for studying compression behavior because formulation and processing conditions can affect compaction and manufacturing outcomes. Research examining these relationships can support improved understanding of tablet formation and compression-related defects. [2]

Research Profile

The supplied researcher record lists Pfizer as the institutional affiliation and identifies Pharmacology, Toxicology and Pharmaceutical Science as the subject area. The supplied bibliographic information records two documents, 25 citations, and an h-index of 2, alongside Scopus author identifier 57223125865. These metrics are bibliographic indicators and should be interpreted in relation to database coverage and publication history. [1]

Research Contributions

The documented studies contribute to the characterization of pharmaceutical powders and compressed tablets. One study evaluates powder rheology as a potential predictor of tablet sticking, while another investigates manufacturing and formulation factors affecting acetaminophen compactability. The 2026 study further develops this research direction by examining glidant type and punch-metal selection in high-drug-load acetaminophen tablets. [2][3][4]

Publications

  • Predicting and Mitigating Sticking in High-Drug-Load Acetaminophen Tablets Using a Powder Rheology-Compression Approach: Evaluation of Glidant Type and Punch Metal Selection. Powders, 2026. [4]
  • Investigating the Impact of Manufacturing and Formulation Factors on the Compactability of Acetaminophen Tablets Using Heckel and Multivariate Analysis. International Journal of Pharmaceutical Sciences and Research, 2021. [2]
  • Evaluation of powder rheology as a potential tool to predict tablet sticking. Powder Technology, 2021. [3]

Research Impact

The reported citation count indicates that the research has received citations within the indexed scholarly literature. Its thematic focus also connects fundamental powder characterization with practical tablet-manufacturing concerns, including sticking and compactability. Such work may be relevant to formulation development and process understanding, although citation metrics alone do not establish practical or clinical impact. [1]

Award Suitability

For consideration in the International Academic Excellence Awards, the documented publication record provides identifiable evidence of research activity in pharmaceutical manufacturing and powder science. The studies present a coherent research theme spanning rheological characterization, compaction analysis, and mitigation of tablet sticking. Award decisions, however, remain subject to the criteria, documentation, and assessment procedures established by the awarding organization. [5]

Conclusion

Joseph Saddik’s documented research is focused on technically specific problems in pharmaceutical tablet manufacture, particularly powder rheology, compactability, and sticking. The available publications demonstrate continuity across these subjects and provide a scholarly basis for describing his research profile within pharmaceutical science. [2][3][4]

References

  1. Elsevier. (n.d.). Scopus author details: Joseph Saddik, Author ID 57223125865. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57223125865
  2. International Journal of Pharmaceutical Sciences and Research. (2021). Investigating the Impact of Manufacturing and Formulation Factors on the Compactability of Acetaminophen Tablets Using Heckel and Multivariate Analysis. DOI: 10.13040/ijpsr.0975-8232.12(2).1240-50
  3. Powder Technology. (2021). Evaluation of powder rheology as a potential tool to predict tablet sticking. DOI: 10.1016/j.powtec.2021.03.062
  4. MDPI. (2026). Predicting and Mitigating Sticking in High-Drug-Load Acetaminophen Tablets Using a Powder Rheology-Compression Approach: Evaluation of Glidant Type and Punch Metal Selection. Powders, 5(3), 31.
    https://doi.org/10.3390/powders5030031
  5. International Academic Excellence Awards. (n.d.). Award program information.
    https://academicexcellenceawards.com/
  6. ORCID. (n.d.). Joseph Saddik, ORCID record 0000-0003-1490-9517.
    https://orcid.org/0000-0003-1490-9517

Rita Ambrus | Toxicology | Best Researcher Award

Published on by Academic Excellence

 Rita Ambrus | Toxicology | Best Researcher Award

Full Professor at College of University of Szeged Institute of Pharmaceutical Technology and Regulatory Affairs, Hungary🎓

Prof. Dr. Rita Ambrus is a distinguished pharmaceutical scientist with a significant impact on modern drug development, particularly in the field of nanotechnology. She holds key academic leadership positions at the University of Szeged, including Vice Dean of the Faculty of Pharmacy and Vice Head of the Institute of Pharmaceutical Technology and Regulatory Affairs. Her research is well-recognized internationally, and she has contributed extensively to the scientific community through her innovative work on drug delivery systems.

Professional Profile 

Scopus

ORCID

🎓Education

Dr. Ambrus has a robust academic background, beginning with her certification as a pharmacist in 2003. She specialized as a pharmaceutical technologist in 2009 and achieved habilitation in 2015. She earned her Ph.D. in 2007, focusing on improving the solubility and dissolution rate of drugs, and later obtained a Doctor of Sciences (D.Sc.) in 2024, with a dissertation on particle size reduction processes in drug development.

💼Work Experience

Dr. Ambrus began her career at the University of Szeged as a central intern in 2006. She quickly advanced to become an assistant lecturer in 2008, followed by an assistant professor in 2014. By 2018, she was promoted to associate professor. In 2024, she was appointed as the Vice Head of the Institute of Pharmaceutical Technology and Regulatory Affairs and later became Vice Dean of the Faculty of Pharmacy. As of September 2024, she holds the position of Full Professor at the University of Szeged.

🔍Research Focus 

Dr. Ambrus’s research is centered on the development of technological processes for reducing particle size in active substances to enhance solubility, dissolution rate, permeability, and biological efficacy. She is particularly focused on alternative drug administration methods, including nasal and pulmonary delivery systems. Her work in nanotechnology has led to significant advancements in pharmaceutical sciences, with a particular emphasis on the development of innovative drug delivery systems.

🏆Awards and Honors

Dr. Ambrus has received numerous prestigious awards throughout her career, including the László Szebellédy Memorial Award in 2023 for her outstanding contributions to pharmaceutical sciences. She has also been recognized as the Young Researcher of the Year by the University of Szeged in 2019 and has been awarded various scholarships, such as the Zoltán Magyary Scholarship and the János Bolyai Research Scholarship, for her pioneering research in nanotechnology.

Conclusion

Prof. Dr. Rita Ambrus is a highly suitable candidate for the Best Researcher Award. Her extensive research contributions, numerous accolades, and leadership roles position her as a leading figure in pharmaceutical technology and drug development. With a strong academic and research background, she exemplifies the qualities sought after for this prestigious recognition. Expanding her international and industry collaborations would further enhance her already impressive portfolio.

📖Publications : 

      1. Improvement of Lidocaine Skin Permeation Using Passive and Active Enhancer Methods (2024) – International Journal of Pharmaceutics 🧴🔬
      2. Exploring Vacuum Compression Molding for Flexible-Dose Pediatric Orodispersible Films (2024) – Pharmaceuticals 👶💊
      3. Holistic Study Design for Hybrid Polymeric Nanoparticulate-Based Dry Powders as Carriers for Ciprofloxacin (2024) – Journal of Pharmaceutical Sciences 🦠💉
      4. Microencapsulation of Grape Pomace Extracts with Alginate-Based Coatings by Freeze-Drying (2024) – Gels 🍇❄️
      5. Fabrication of Ciprofloxacin-Loaded Sodium Alginate Nanobeads Coated with Thiol-Anchored Chitosan (2024) – Pharmaceutics 🧪💊
      6. Characterization of Grape Pomace Extract Microcapsules Using Carbohydrate Co-Coating (2024) – Foods 🍇🥛
      7. Preparation of a Nanosized Piroxicam Containing Orodispersible Lyophilizate (2024) – Micromachines 🌡️🧫
      8. Spray-Dried Chitosan Hydrogel Particles as a Delivery System for Benzydamine Hydrochloride (2024) – Gels 💧🦠
      9. Pulsed Laser Ablation of Polymer-Based Magnetic Nanocomposites for Oil Spill Remediation (2024) – Cleaner Materials 🌊🧲
      10. Development of a Novel Combined Dry Powder Inhaler for Pulmonary Inflammations (2024) – Pharmaceuticals 🫁